ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Kidney Week 2020: Embargo Policy

ASN is committed to doing everything we can to help our members and the rest of the kidney community care for people with kidney diseases and adjust to this new reality resulting from the COVID-19 pandemic. With the cancellation of some nephrology meetings as well as the transition from live to virtual of other nephrology meetings, ASN has received requests for the Society to accommodate abstracts that were accepted at other nephrology meetings in 2020 to be submitted for consideration at this year's Kidney Week.

For Kidney Week 2020, ASN has updated its standard embargo policy and will consider submissions of research abstracts and clinical case reports that were published and/or presented in 2020.

Please read and adhere to the following embargo policy for ASN Kidney Week abstracts.

  • This ASN embargo policy for ASN Kidney Week abstracts (i.e., research abstracts and clinical case reports), oral presentations, and posters supersedes all other embargoes.
  • Accepted Kidney Week abstracts, with the exception of late-breaking clinical trials, will be posted online on October 9, 2020. Titles of accepted late-breaking clinical trials will be posted online on October 9, 2020.
  • ASN will not accept an abstract submission if the abstract:
    1. has been published prior to January 1, 2020, or
    2. has been presented (oral or poster) at another meeting or press conference prior to January 1, 2020.
  • Any information beyond what is contained in the four corners of the abstract may not be released until ASN lifts the embargo. With permission of the authors, ASN may selectively lift the embargo prior to presentation at Kidney Week to coincide with ASN Kidney Week press briefing schedules or other press promotions.

Late-Breaking Clinical Trials: All accepted late-breaking clinical trial oral presentations and posters are under embargo until time of presentation at the ASN meeting. If this embargo policy is violated, ASN reserves the right to sanction the violator (authors or press).